Andrew Jackson

• Head, Global Corporate Security and Aviation
  Novartis International

BA (Hons), Modern Languages; MSc (Hons), Security and Crime Risk Management; linguist in Russian and Czech. Government service prior to 1998 includes: UK Foreign and Commonwealth Office (Diplomatic Service) security and intelligence functions in the UK, Latin America, Central and Eastern Europe. Former: Security Adviser, Société Générale de Surveillance; independent security consultant. 2002-08, Executive Director, Corporate Security, Novartis, Switzerland; 2008-09, Vice-President, Corporate Security, Novartis Corporation, New Jersey, US. Since August 2009, Head of Global Corporate Security and Corporate Aviation, Novartis International, Switzerland, responsible for: product security programmes, extremism risk strategy, physical and technical security, fraud and misconduct investigation management, executive protection; management of an international team of 50 corporate security professionals; representation of Novartis at pharmaceutical anti-counterfeiting forums, including the Pharmaceutical Security Institute, EFPIA and WHO IMPACT.